Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Germany's Merck"


5 mentions found


Merck, seen as leading the race to win approval for a more targeted type of MS drug, said in April that U.S. regulators had paused enrolment of new patients into a trial testing the drug, evobrutinib, knocking the German drugmaker's share price. "The readout of our Phase 3 study is going to happen in December," she added of the pivotal study in the clinical trials process. Novartis (NOVN.S), also in the race, said in April that no signs of liver damage had been seen in trials testing its anti-inflammatory drug candidate remibrutinib so far. Roche (ROG.S) said in May that its BTK inhibitor against MS, reduced brain lesions associated with the disease in a mid-stage trial and that no new safety concerns had emerged. Reporting by Ludwig Burger Editing by Bill BerkrotOur Standards: The Thomson Reuters Trust Principles.
Persons: Germany's Merck, Belen Garijo, ROG.S, Ludwig Burger, Bill Berkrot Organizations: Germany's, Merck, U.S . Food, Drug Administration, Reuters, Rivals, Sanofi, Novartis, Thomson Locations: FRANKFURT, U.S, Darmstadt
Germany's Merck flags steeper drop in earnings
  + stars: | 2023-08-03 | by ( Ludwig Burger | ) www.reuters.com   time to read: +2 min
A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. Earnings before interest, taxes, depreciation and amortisation (EBITDA), before one-offs, would fall between 3% and 9%, when adjusted for currency swings, the diversified company said. The foreign exchange effects would be an additional drag of between 3% and 6%, it added. It had previously forecast 2023 adjusted EBITDA to slip between 0% and 5%, with an additional negative foreign exchange effect of 2% to 5%. Merck also reported second-quarter adjusted EBITDA declined 12.8% to 1.55 billion euros ($1.69 billion), slightly above the average estimate of 1.5 billion euros in an analyst poll on the company's website.
Persons: Ralph Orlowski, Merck, drugmakers, Ludwig Burger, Maria Sheahan, Miranda Murray, Kim Coghill Organizations: Merck, REUTERS, Science, Thomson Locations: Darmstadt, Germany, COVID
Helene von Roeder to become new CFO of Germany's Merck
  + stars: | 2023-05-08 | by ( ) www.reuters.com   time to read: 1 min
[1/2] People sit next to a Merck logo at SEMICON Taiwan in Taipei, Taiwan, September 14, 2022. REUTERS/Ann WangMay 8 (Reuters) - Germany's Merck KGaA (MRCG.DE) has appointed Helene von Roeder as the new chief financial officer and member of the Executive Board after Marcus Kuhnert has decided to step down, the drugmaker announced on Monday. The changes would become effective from July 1, the company added. German real estate company Vonovia (VNAn.DE) announced this month that von Roeder would be leaving its management board at her own request as of July 1. (This story has been refiled to make it clear that the company is Germany's Merck)Reporting by Anastasiia Kozlova and Amir Orusov Editing by Miranda MurrayOur Standards: The Thomson Reuters Trust Principles.
Germany's Merck to invest 300 million euros in US gas plant
  + stars: | 2023-04-12 | by ( ) www.reuters.com   time to read: 1 min
April 12 (Reuters) - Germany's Merck (MRCG.DE) will invest about 300 million euros ($327.90 million) in the world's largest integrated specialty gas plant in Hometown, U.S., the company said on Wednesday. The agreement with the U.S. state of Pennsylvania supports "expansion of manufacturing capacity for the semiconductor industry", it added. The science and technology group plans to invest "significantly more than 3 billion euros" in innovations and capacity expansions to ensure the success of its semiconductor solutions branch, it said in a press release. ($1 = 0.9149 euros)Reporting by Andrey Sychev in Gdansk, Editing by Rachel MoreOur Standards: The Thomson Reuters Trust Principles.
Meanwhile, Merck's investment strategy in China has not changed but the healthcare and chip materials maker is "mindful of the potential risks", Garijo noted in the Reuters Newsmaker interview. China is a key region for the semiconductor industry and drug companies, but geopolitical challenges are growing. While Taiwan has lived under the Chinese threat for decades, war games in early August have rattled nerves in the semiconductor industry. There is a need for "constructive dialogue" with markets like China that are important to German industry, and Merck, said Garijo. "We are mindful of the potential risks ... but our investment policy has not changed," she said.
Total: 5